The asthmas in 2015 and beyond: A Lancet Commission

The Lancet

Volumn 385, Issue 9975, 2015, Pages 1273-1275

  Bush, Andrew ^a,b   Kleinert, Sabine ^c   Pavord, Ian D ^d  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c London Center   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 8; LEUKOTRIENE B4; ANTIASTHMATIC AGENT;

ASTHMA; CLINICAL FEATURE; HUMAN; LONG TERM CARE; LUNG FUNCTION; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT INFLAMMATION; RISK ASSESSMENT; SUDDEN DEATH; WHEEZING; INHALATIONAL DRUG ADMINISTRATION; MEDICAL RESEARCH; TRENDS;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOMEDICAL RESEARCH; HUMANS; PRACTICE GUIDELINES AS TOPIC;

EID: 84926500070     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(15)60654-7     Document Type: Note

References (15)

1. Guidelines for management of asthma in adults: I - chronic persistent asthma Statement by the British Thoracic Society, Research Unit of the Royal College of Physicians of London, King's Fund Centre, National Asthma Campaign BMJ 301 1990 651 653
2. M Levy, R Andrews, R Buckingham et al. Why asthma still kills: the National Review of Asthma Deaths (NRAD) Confidential Enquiry report 2014 Royal College of Physicians London
3. ID Pavord, CE Brightling, G Woltmann, AJ Wardlaw Non-eosinophilic corticosteroid unresponsive asthma Lancet 353 1999 2213 2214
4. FE Hargreave, P Nair The definition and diagnosis of asthma Clin Exp Allergy 39 2009 1652 1658
5. MK Han, N Tayob, S Murray et al. Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy Am J Respir Crit Care Med 189 2014 1503 1508
6. A Bush, ID Pavord Following Nero: fiddle while Rome burns, or is there a better way? Thorax 66 2011 367 368
7. A Bush Inhaled corticosteroid and children's growth Arch Dis Child 99 2014 191 192
8. I Sabroe, D Postma, I Heijink, DH Dockrell The yin and the yang of immunosuppression with inhaled corticosteroids Thorax 68 2013 1085 1087
9. ID Pavord, DE Shaw, PG Gibson, DR Taylor Inflammometry to assess airways disease Lancet 372 2008 1017 1019
10. M Rosenthal CON: encouraging resistance to rule-based medicine is essential to improving outcomes Thorax 70 2015 112 114
11. P Flood-Page, C Swenson, I Faiferman et al. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma Am J Respir Crit Care Med 176 2007 1062 1071
12. P Haldar, CE Brightling, B Hargadon et al. Mepolizumab (anti-IL 5) and exacerbations of refractory eosinophilic asthma N Engl J Med 360 2009 973 984
13. ID Pavord, S Korn, P Howarth et al. Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo controlled trial Lancet 380 2012 651 659
14. J Corren, RF Lemanske, NA Hanania et al. Lebrikizumab treatment in adults with asthma N Engl J Med 365 2011 1088 1098
15. S Wenzel, L Ford, D Pearlman et al. Dupilumab in persistent asthma with elevated eosinophil levels N Engl J Med 368 2013 2455 2466